Schmerzen nach Schlaganfall

Zusammenfassung

Menschen nach einem Schlaganfall haben ein hohes Risiko, chronische Schmerzen zu entwickeln. Neben den zentralen Schmerzen, die ihre direkte Ursache in der läsionellen Schädigung des ZNS haben, gilt es auch, jene Schmerzsyndrome ins Blickfeld zu nehmen, die sich als Folge der Parese oder einer sich entwickelnden Spastizität und der hiermit verbundenen motorischen Fehlfunktionen erklären. Eine genaue Diagnose des Schmerzsyndroms ist für die gezielte Therapie eine zwingende Voraussetzung.

Summary

Post-stroke patients are at risk to develop chronic pain. Besides central post-stroke pain which originates in a central nervous lesion, those pain syndromes need attention which are caused by paresis or a developing spasticity, and the consequential motor disorder. The precise diagnosis of the pain syndrome is a prerequisite for a targeted therapy.

Schlüsselwörter

Schmerz - Schlaganfall - Spastizität

Keywords

Pain - stroke - spasticity

• Literatur

• 1 Henry JL, Panju A, Yahpal K. (eds). Central neuropathic pain: Focus on poststroke pain. Seattle: IASP Press; 2007
• 2 Canavero S, Bonicalzi V. Central pain syndrome: elucidation of genesis and treatment. Expert review of neurotherapeutics 2007; 07 (11) 1485-97.
• 3 Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118 (03) 289-305.
• 4 Burchiel KJ, Yezierski RP. (eds). Spinal cord injury pain: assessment, mechanisms, management. Seattle: IASP; 2002
• 5 Leijon G, Boivie J, Johansson I. Central post-stroke pain--neurological symptoms and pain characteristics. Pain 1989; 36 (01) 13-25.
• 6 Gustin SM, Wrigley PJ, Gandevia SC, Middleton JW, Henderson LA, Siddall PJ. Movement imagery increases pain in people with neuropathic pain following complete thoracic spinal cord injury. Pain 2008; 137 (02) 237-44.
• 7 Head H, Holmes G. Sensory disturbances from central lesions. Brain 1911; 34: 102-254.
• 8 Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain 1995; 61 (02) 187-93.
• 9 Finnerup NB, Johannesen IL, Fuglsang-Frederiksen A, Bach FW, Jensen TS. Sensory function in spinal cord injury patients with and without central pain. Brain 2003; 126 (Pt 1): 57-70.
• 10 Finnerup NB, Jensen TS. Spinal cord injury pain--mechanisms and treatment. Eur J Neurol 2004; 11 (02) 73-82.
• 11 Craig AD, Bushnell MC, Zhang ET, Blomqvist A. A thalamic nucleus specific for pain and temperature sensation. Nature 1994; 372 (6508): 770-3.
• 12 Craig AD. Supraspinal pathways and mechanisms relevant to central pain. In: Casey KL. (ed). Pain and central nervous disease: the central pain syndromes. New York: Raven Press; 1991
• 13 Wasner G, Lee BB, Engel S, McLachlan E. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 2008; 131 (Pt 9): 2387-400.
• 14 Rolke R. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123 (03) 231-43.
• 15 Baron R. Mechanisms of disease: neuropathic pain--a clinical perspective. Nature clinical practice 2006; 02 (02) 95-106.
• 16 Siddall PJ, Middleton JW. A proposed algorithm for the management of pain following spinal cord injury. Spinal Cord 2006; 44 (02) 67-77.
• 17 Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006; 67 (10) 1792-800.
• 18 Cruccu G. et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14 (09) 952-70.
• 19 Rasche D, Ruppolt M, Stippich C, Unterberg A, Tronnier VM. Motor cortex stimulation for longterm relief of chronic neuropathic pain: a 10 year experience. Pain 2006; 121 (1–2): 43-52.
• 20 Bender L, McKenna K. Hemiplegic shoulder pain: defining the problem and its management. Disability and rehabilitation 2001; 23 (16) 698-705.
• 21 Wissel J. et al. Management of spasticity associated pain with botulinum toxin A. Journal of pain and symptom management 2000; 20 (01) 44-9.
• 22 Wasner G, Schattschneider J, Binder A, Baron R. Complex regional pain syndrome--diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord 2003; 41 (02) 61-75.
• 23 Schott GD. Complex? Regional? Pain? Syndrome?. Practical neurology 2007; 07 (03) 145-57.
• 24 Jonsson AC, Lindgren I, Hallstrom B, Norrving B, Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. Journal of neurology, neurosurgery, and psychiatry 2006; 77 (05) 590-5.
• 25 Diamond PT. Rehabilitative management of poststroke visuospatial inattention. Disability and rehabilitation 2001; 23 (10) 407-12.
• 26 Chatterton HJ, Pomeroy VM, Gratton J. Positioning for stroke patients: a survey of physiotherapists’ aims and practices. Disability and rehabilitation 2001; 23 (10) 413-21.
• 27 Snels IA. et al. Effect of triamcinolone acetonide injections on hemiplegic shoulder pain : A randomized clinical trial. Stroke; a journal of cerebral circulation 2000; 31 (10) 2396-401.
• 28 Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. Journal of neurology, neurosurgery, and psychiatry 2007; 78 (08) 845-8.
• 29 de Boer KS, Arwert HJ, de Groot JH, Meskers CG, Mishre AD, Arendzen JH. Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. Journal of neurology, neurosurgery, and psychiatry 2008; 79 (05) 581-3.
• 30 Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA. Use of botulinum toxin in stroke patients with severe upper limb spasticity. Journal of neurology, neurosurgery, and psychiatry 1996; 61 (01) 30-5.